Related Experiment Video

Updated: Aug 29, 2026

Utilizing High Resolution Ultrasound to Monitor Tumor Onset and Growth in Genetically Engineered Pancreatic Cancer Models
06:57

Utilizing High Resolution Ultrasound to Monitor Tumor Onset and Growth in Genetically Engineered Pancreatic Cancer Models

Published on: April 7, 2018

Targeting Sonic Hedgehog: a new way to mow down pancreatic cancer?

Keith A Cengel1

  • 1Department of Radiation Oncology, 3400 Spruce Street, 2 Donner, Philadelphia, Pennsylvania 19104, USA. Cengel@mail.med.upenn.edu

Cancer Biology & Therapy
|February 7, 2004
PubMed

Insights

Pancreatic cancer has a poor prognosis, partly due to molecular issues affecting treatment sensitivity. Targeting Sonic Hedgehog (Shh) signaling with drugs like cyclopamine shows promise for new pancreatic cancer therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Pancreatic cancer prognosis remains poor despite advances in treatment.
  • Molecular abnormalities drive pancreatic tumorigenesis and treatment resistance.
  • Sonic Hedgehog (Shh) signaling is implicated in pancreatic cancer development.

Purpose of the Study:

  • To investigate the role of Sonic Hedgehog (Shh) signaling in pancreatic cancer.
  • To evaluate the efficacy of Shh pathway inhibition in pancreatic cancer treatment.

Main Methods:

  • Review of recent studies published in Nature.
  • Analysis of Sonic Hedgehog (Shh) overexpression in pancreatic tumors.
  • Assessment of cyclopamine's effect on pancreatic cancer cell growth and viability.

Main Results:

  • Sonic Hedgehog (Shh) overexpression is linked to pancreatic tumorigenesis.
  • Cyclopamine, an Shh signaling inhibitor, reduced pancreatic cancer cell growth.
  • Cyclopamine decreased pancreatic cancer cell viability.

Conclusions:

  • Sonic Hedgehog (Shh) signaling is a potential driver of pancreatic cancer.
  • Targeting Shh signaling represents a novel therapeutic strategy for pancreatic cancer.
  • Cyclopamine demonstrates potential as a pancreatic cancer treatment agent.

More Related Videos

A Syngeneic Pancreatic Cancer Mouse Model to Study the Effects of Irreversible Electroporation08:05

A Syngeneic Pancreatic Cancer Mouse Model to Study the Effects of Irreversible Electroporation

Published on: June 8, 2018

Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation14:10

Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation

Published on: December 15, 2010

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...